1.32
9.09%
+0.11
After Hours:
1.35
0.03
+2.27%
Ekso Bionics Holdings Inc stock is currently priced at $1.32, with a 24-hour trading volume of 53,527.
It has seen a +9.09% increased in the last 24 hours and a -2.94% declined in the past month.
The chart indicates a potential bullish trend, as the stock is above the $1.22 pivot point. If it approaches the $1.36 resistance level, significant changes may occur.
Ekso Bionics Holdings Inc Stock (EKSO) Financials Data
Ekso Bionics Holdings Inc (EKSO) Revenue 2024
EKSO reported a revenue (TTM) of $18.28 million for the quarter ending December 31, 2023, a +41.57% rise year-over-year.
Ekso Bionics Holdings Inc (EKSO) Net Income 2024
EKSO net income (TTM) was -$15.20 million for the quarter ending December 31, 2023, a -0.78% decrease year-over-year.
Ekso Bionics Holdings Inc (EKSO) Cash Flow 2024
EKSO recorded a free cash flow (TTM) of -$12.21 million for the quarter ending December 31, 2023, a +17.95% increase year-over-year.
Ekso Bionics Holdings Inc (EKSO) Earnings per Share 2024
EKSO earnings per share (TTM) was -$1.10 for the quarter ending December 31, 2023, a +5.17% growth year-over-year.
Ekso Bionics Holdings Inc Stock (EKSO) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
Lathan Corinna | Director |
Aug 23 '23 |
Buy |
0.95 |
5,500 |
5,222 |
143,958 |
Davis Scott G. | President & COO |
Aug 17 '23 |
Sale |
1.00 |
37,446 |
37,281 |
331,372 |
Wong Jerome | Chief Financial Officer |
Aug 17 '23 |
Sale |
1.00 |
12,784 |
12,728 |
266,953 |
Lathan Corinna | Director |
Aug 10 '23 |
Buy |
1.25 |
4,201 |
5,251 |
138,458 |
SHERMAN STEVEN | Executive Chair |
May 24 '23 |
Sale |
1.44 |
45,660 |
65,874 |
364,913 |
Jones Jason C | Chief Operating Officer |
May 08 '23 |
Sale |
1.57 |
3,435 |
5,401 |
138,554 |
Ekso Bionics Holdings Inc Stock (EKSO) Latest News
Ekso Bionics Receives Final Payment Determination for Medicare Reimbursement from the Centers for Medicare & Medicaid Services (CMS) for Ekso Indego Personal
GlobeNewswire Inc.
Cognition Therapeutics And 2 Other Stocks Under $2 Insiders Are Buying
Benzinga
Why SOPHiA GENETICS Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Benzinga
Why Paymentus Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
Benzinga
Ekso Bionics (EKSO) Reports Q4 Loss, Tops Revenue Estimates
Zacks Investment Research
Ekso Bionics Reports Record Annual Revenue of $18.3 Million
GlobeNewswire Inc.
About Ekso Bionics Holdings Inc
Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Europe, the Middle east, Africa, the Asia Pacific, and internationally. The company operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. It also provides EksoNR, a wearable bionic suit and rehabilitation device that assists physical therapists and physicians to treat patients with acquired brain injury, stroke, and spinal cord injury; and EksoUE is a wearable upper extremity assistive device that helps to reduce the effect of gravity on the wearer's shoulders and arms. Ekso Bionics Holdings, Inc. has a license agreement with Lockheed Martin Corporation. The company was incorporated in 2005 and is headquartered in Richmond, California.
Cap:
|
Volume (24h):